Blog
RSS FeedPosted by Michael Wonder on 14 Apr 2020
Why a decades old TB vaccine is getting attention in the fight against COVID-19
14 April 2020 - In the desperate search for ammunition to fend off the COVID-19 pandemic, a decades old tuberculosis ...
Posted by Michael Wonder on 09 Apr 2020
Global regulators stress need for robust evidence on COVID-19 treatments
9 April 2020 - International regulators have published a report today highlighting their considerations on the development of potential COVID-19 ...
Posted by Michael Wonder on 02 Apr 2020
Clinical trial of Gilead’s coronavirus hopeful remdesivir begins in UK
2 April 2020 - The pair of phase 3 trials will take place across 15 clinical sites in the UK. ...
Posted by Michael Wonder on 31 Mar 2020
Clinical trial processes
31 March 2020 - The TGA has received a number of enquiries about processes for clinical trials relating to COVID-19 ...
Posted by Michael Wonder on 30 Mar 2020
FDA guidance on conduct of clinical trials of medical products during the COVID-19 pandemic
30 March 2020 - The U.S. FDA today issued an updated guidance, “Conduct of Clinical Trials of Medical Products during ...
Posted by Michael Wonder on 26 Mar 2020
COVID-19: frontline virus fighters to trial TB vaccine
27 March 2020 - Thousands of Australian doctors, nurses and health workers will be given a tuberculosis vaccine in a ...
Posted by Michael Wonder on 26 Mar 2020
Preserving clinical trial integrity during the coronavirus pandemic
25 March 2020 - Randomised clinical trials provide the highest-quality evidence for identifying therapies to help people attain longer and healthier ...
Posted by Michael Wonder on 25 Mar 2020
COVID-19 and angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: what is the evidence?
24 March 2020 - Coronavirus disease 2019 is a current pandemic infection caused by a positive-sense RNA virus named the severe ...
Posted by Michael Wonder on 25 Mar 2020
Treating COVID-19—off-label drug use, compassionate use, and randomised clinical trials during pandemics
24 March 2020 - In the 2014 Ebola outbreak, close to 30 000 individuals developed Ebola viral disease, and numerous therapies were ...
Posted by Michael Wonder on 24 Mar 2020
Global regulators map out data requirements for phase 1 COVID-19 vaccine trials
24 March 2020 - Global regulators have published a report today presenting the outcomes of a workshop on COVID-19 vaccine ...
Posted by Michael Wonder on 24 Mar 2020
Coronavirus drug to be trialled on frontline health workers
25 March 2020 - Australia is moving towards a new coronavirus preventive trial for frontline healthcare workers as the number of ...
Posted by Michael Wonder on 23 Mar 2020
Rush to raise funds for large COVID-19 drug trial in Australian hospitals
23 March 2020 - Australian researchers behind a new clinical trial of two drugs to treat COVID-19 are desperate to ...
Posted by Michael Wonder on 18 Mar 2020
Coronavirus (COVID-19) update: FDA issues guidance for conducting clinical trials
18 March 2020 - The U.S. Food and Drug Administration today issued a guidance for industry, investigators and institutional review ...
Posted by Michael Wonder on 04 Mar 2020
When a drug study abruptly ends, volunteers are left to cope
3 March 2020 - A participant might commit months or years to a drug trial, only to see it vanish overnight. ...
Posted by Michael Wonder on 18 Feb 2020
Paying clinical trial participants: legal risks and mitigation strategies
18 February 2020 - Offering remuneration to participants in cancer trials can promote recruitment and retention. ...